Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect

J Biol Chem. 2000 Nov 10;275(45):35215-23. doi: 10.1074/jbc.M004446200.

Abstract

Enrichment of Neuro 2A cells with docosahexaenoic acid (22:6n-3) decreased apoptotic cell death induced by serum starvation as evidenced by the reduced DNA fragmentation and caspase-3 activity. The protective effect of 22:6n-3 became evident only after at least 24 h of enrichment before serum starvation and was potentiated as a function of the enrichment period. During enrichment 22:6n-3 incorporated into phosphatidylserine (PS) steadily, resulting in a significant increase in the total PS content. Similar treatment with oleic acid (18:1n-9) neither altered PS content nor resulted in protective effect. Hindering PS accumulation by enriching cells in a serine-free medium diminished the protective effect of 22:6n-3. Membrane translocation of Raf-1 was significantly enhanced by 22:6n-3 enrichment in Neuro 2A cells. Consistently, in vitro biomolecular interaction between PS/phosphatidylethanolamine /phosphatidylcholine liposomes, and Raf-1 increased in a PS concentration-dependent manner. Collectively, enrichment of neuronal cells with 22:6n-3 increases the PS content and Raf-1 translocation, down-regulates caspase-3 activity, and prevents apoptotic cell death. Both the antiapoptotic effect of 22:6n-3 and Raf-1 translocation are sensitive to 22:6n-3 enrichment-induced PS accumulation, strongly suggesting that the protective effect of 22:6n-3 may be mediated at least in part through the promoted accumulation of PS in neuronal membranes.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Caspase 3
  • Caspases / metabolism
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Culture Media, Serum-Free
  • DNA Fragmentation / drug effects
  • Docosahexaenoic Acids / pharmacology*
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Immunoblotting
  • Liposomes / metabolism
  • Neurons / drug effects*
  • Neurons / pathology*
  • Oleic Acid / pharmacology
  • PC12 Cells
  • Phosphatidylcholines / pharmacology
  • Phosphatidylethanolamines / pharmacology
  • Phosphatidylserines / physiology*
  • Proto-Oncogene Proteins c-raf / metabolism
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Time Factors
  • Translocation, Genetic

Substances

  • Culture Media, Serum-Free
  • Liposomes
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Phosphatidylserines
  • Docosahexaenoic Acids
  • Oleic Acid
  • Proto-Oncogene Proteins c-raf
  • Casp3 protein, rat
  • Caspase 3
  • Caspases